Prevention of biomaterial-associated infections (BAI) remains a challenging problem, in particular due to the increased risk of resistance development with the current antibioticbased strategies. Metallic orthopaedic devices, such as non-cemented implants, are often inserted under high mechanical stress. These non-cemented implants cannot be protected by e.g. antibiotic releasing bone cement or other antimicrobial approaches such as the use of bioactive glass. Therefore, we developed an antimicrobial coating for orthopaedic implants to prevent Staphylococcus aureus BAI with high mechanical stability in order to avoid abrasion during implantation procedures. We incorporated 5 and 10 wt% chlorhexidine in a novel mechanically stable epoxy-based coating, designated CHX 5 and CHX 10 , respectively.
INTRODUCTION
Medical devices manufactured from titanium, such as prosthetic joints and dental implants, are widely used in modern medicine. Titanium's lightness, good mechano-chemical and osseo-integrative properties make it an ideal material for bone implant application. 1 Unfortunately, as with any inserted or implanted foreign body material 2, 3 , a significant problem with titanium implants is the risk of infection. These so-called biomaterialassociated infections (BAI) are feared complications in orthopaedic and trauma surgery with tremendous consequences for the patients. The majority of BAIs are caused by staphylococci,
especially Staphylococcus epidermidis and Staphylococcus aureus 4, 5 . Formation of a biofilm consisting of bacteria, bacterial products and host proteins on the biomaterial surface is considered the major element in the pathogenesis of BAI 6 . In addition, the presence of the foreign body material leads to colonization of tissue surrounding implants [7] [8] [9] [10] [11] .
In order to prevent infection of medical devices, a variety of surface modifications have been developed. These include non-adhesive, contact-killing and tissue-integrating surfaces, as well as coatings for the controlled release of antimicrobial agents 12, 13 . To prevent both colonization of the implant itself and of the tissue surrounding the implant, an antimicrobial-releasing coating is preferred. However, the use of antibiotics on a medical device is discouraged by government regulatory agencies, especially the American Food and Drug Administration (FDA), in view of the increasing development of resistance 13, 14 . As an alternative for antibiotics, commonly used antiseptics such as chlorhexidine might be used.
Chlorhexidine has broad antimicrobial activity and has been shown to prevent infection in patients and in animal models. It is used topically, for site preparation in surgical procedures, and also intracorporally, e.g. in rapid sterilization of exposed tissues in abdominal surgery prior to wound closure 15 . Moreover, chlorhexidine is widely applied as an irrigant fluid in dentistry with low toxicity and good tolerability in soft tissue 16 . In biomaterials, chlorhexidine has been applied in combination with silver-sulfadiazine in a coating on intravenous catheters, which decreased catheter-related infection in humans 17 . Experimental titanium tibia intramedullary nails coated with chlorhexidine and chloroxylenol had reduced rates of orthopaedic device-related infection in rabbits 18, 19 .
In the present study we aimed to design an antimicrobial coating for titanium implants for general application in orthopaedics and trauma, with high mechanical stability in order to avoid abrasion during implantation procedures. Coatings and materials manufactured from epoxy resins are among the few available that meet this requirement 20, 21 . Epoxy resins can be catalytically cross-linked or they can be cured using reagents such as polyamines. The typically good adhesion to metallic substrates and good mechanical properties of epoxybased coatings [22] [23] [24] prompted us to investigate an epoxy-amine coating network containing chlorhexidine as the antimicrobial agent for orthopaedic implants. Dopamine is added to the coating because the catechol moiety of dopamine is known for its strong adhesion to a range of metallic substrates, including medical-grade titanium [25] [26] [27] .
The purpose of the present study was therefore to develop an epoxy-based chlorhexidine-releasing coating for titanium implants with potent in vitro as well as in vivo antibacterial activity in a murine subcutaneous implant infection model. In this model, the release of chlorhexidine proved to be effective in preventing S. aureus colonization of the implants and surrounding tissue without signs of toxicity.
MATERIALS AND METHODS

COATING PREPARATION
Coating formulations as described in Table 1 . In this report, the Table 1 . Coating formulation compositions. Batch 1 was used for spin-coating of the aluminium sheets and Q-panels and titanium disks, batch 2 for dip-coating of the in vivo titanium implants. To obtain a similar coating thickness in both coating procedures, the viscosity of the formulation had to be lower in case of the dip-coating procedure and therefore a lower solids in EtOH content was used in batch 2.
coating formulations were designated CHX 0 (no chlorhexidine), CHX 5 (5 wt% chlorhexidine) and CHX 10 (10 wt% chlorhexidine). Two batches of the CHX 0 and CHX 10 coating formulations were prepared. The chemical composition was kept maximally constant in both batches with particular attention to the ratio between the amino groups and the epoxy groups determining the crosslink density. The coating formulations of CHX 0 (1 st batch), CHX 5 and CHX 10 (1 st batch) were used to coat aluminium sheets and titanium disks for the in vitro assays. The second batch CHX 0 and CHX 10 formulations were used to coat the titanium implants for the in vivo assays. Formulations were prepared fresh prior to application to the different materials.
APPLICATION OF COATING TO ALUMINIUM SHEETS AND TITANIUM DISCS VIA SPIN-COATING
For the in vitro experiments, coatings were applied on aluminium sheets (5 × 5 cm) and Q-panels (15.3 × 10.1 cm), and medical grade titanium (Ti 6Al-4V ELI, surface finish 2B (ASTM A480)) discs (diameter 20 mm, height 1 mm), which had been cleaned by submerging in ethanol and acetone and subsequent treatment with ultrasound for 5 min. Aliquots of approximately 1 ml and 0.1 -0.2 ml of the coating formulation were applied to the surface of aluminium sheets and titanium disks, respectively, and the samples were spin-coated at a rotation speed of 1,000 rpm for 30 sec. The samples were air-dried for 0.5 -2 h and subsequently placed in an oven at ~90 °C for 3 h.
APPLICATION OF COATINGS TO TITANIUM IMPLANTS VIA DIPPING
For the in vivo experiments, medical-grade titanium implants (10 × 4 × 1 mm, with a slit to allow cutting of the implant after explantation, see below) were manufactured by Flowcut (Nederweert, The Netherlands) and coated using the following procedure. First, the implants were cleaned by boiling them for 1 h in 10 wt% aqueous NaOH, followed by washing by 
MECHANICAL STABILITY ASSAYS SOLVENT RESISTANT ASSAY
A double rub test was used to assess the mechanical stability of the coatings under dry conditions. A number of the coated aluminium Q-panels were washed for 48 h in PBS at 37
°C to assess the mechanical stability of the coatings under wet conditions. The double rub test was performed essentially as described in the solvent resistance standard test method (ASTM D5402), with some modifications. In short, a piece of felt (diameter 2 cm), soaked in EtOH (more appropriate solvent than methyl ethyl ketone (MEK) used in ASTM D5402), was moved back and forth (1 double rub) over a distance of 12 cm (in 1 s) using an automated rubbing apparatus (DSM, in house equipment) on a defined area of the coated substrate with a constant load of 400 g. When macroscopic damage to the coating was observed, the test was stopped and the number of rubs were noted. A maximum of 200 double-rubs was applied and the resistance was rated by eye on a 0 -5 scale, with 0 meaning penetration to the substrate in 200 double rubs or less and 5 meaning no effect on surface after 200 double rubs.
TAPE ADHESION TEST
The adhesion of the coating to the substrate was tested essentially as described in the tape standard test method (ASTM D3359). Due to the coating hardness, it was not possible to make cuts as described in ASTM D3359 prior to the procedure. In short, 25 mm wide semi-transparent pressure-sensitive tape was pressed firmly onto a defined area of the coating and pulled off rapidly under an angle close to 180°. The test was repeated on two other sites of the coated aluminium Q-panels, and the level of adhesion was rated by eye on 0 -5 scale, with 0 meaning full removal of the coating and 5 meaning no peeling or removal of the coating.
SCANNING ELECTRON MICROSCOPY
A JEOL JSM-IT100 scanning electron microscope (SEM; JEOL, Tokyo, Japan) was used to examine non-coated and CHX 10 -coated titanium implants. Before imaging, specimens were sputter-coated with carbon layer of ~6 nm thickness. The images were collected at an acceleration voltage of 5 -15 kV.
ATOMIC FORCE MICROSCOPY
Atomic force microscopy (AFM) was performed with an AFM Dimension Edge (Bruker, Camarillo, CA, USA). Non-coated and CHX 10 -coated titanium implants were scanned in tapping mode with a standard silicon cantilever at a resonance frequency of 370 kHz and a scan rate of 0.5 Hz using a tip with a radius of 10 nm and a height of 10 -15 µm. The average surface roughness (R a ) was quantified on three different locations of each sample using images of 100 × 100 µm 2 , and presented as average with standard deviation.
BACTERIA
S. aureus ATCC 49230 is a biofilm-producing strain 28 originally isolated from a patient with osteomyelitis 29 . In order to verify the identity of the challenge strain after re-isolation in the in vivo studies, we constructed a green fluorescent S. aureus ATCC 49230 strain by introducing plasmid WVW189, essentially as described earlier 30 . This plasmid carries the gfp uvr gene under control of a constitutive S. aureus promoter, and a chloramphenicol resistance gene for selection 31 . The strain, S. aureus ATCC 49230 GFP, was designated S.
aureus GFP in this paper, for brevity. The plasmid was stably maintained by the S. aureus GFP bacteria even in absence of chloramphenicol during growth. Chloramphenicol (10 µg/ ml) was however always added to cultures of the strain used to prepare inocula, in order to avoid any potential loss of the plasmid. The susceptibility to chlorhexidine and the growth rate in tryptic soy broth (TSB; BD Difco) of S. aureus GFP and of the wild type S. aureus ATCC 49230 were equal (data not shown). In previous studies we showed that the presence of
plasmid WVW189 did not influence the virulence of S. epidermidis in mice 30 .
SURFACE BACTERICIDAL ACTIVITY ASSAY
A modified version 32 of the Japanese Industrial Standard test for surface microbicidal activity (JIS Z 2801:2000 33 ) was used to evaluate the bactericidal activity of quadruplicate coated titanium disks against S. aureus. In short, S. aureus was cultured in TSB with 10 µg/ ml chloramphenicol to the logarithmic growth phase at 37 °C, shaking. Subsequently, the bacteria were diluted with TSB to 10 7 colony forming units (CFU)/ml, based on the optical density at 620 nm (OD 620 ). UV-sterilized nitrocellulose filter disks (diameter 13 mm) were placed on a Colombia sheep blood agar plate and 20 µl of the diluted bacterial culture, containing 2 × 10 5 CFU, was pipetted onto the filters. The medium was absorbed by the agar while the bacteria were retained on the filter. Twenty µl of 1% TSB in 10 mM phosphate buffer was pipetted centrally on the surface of each titanium disk and an inoculated filter disk was carefully placed on top, with the bacteria contacting the coated surface. All disks with bacterial filters were placed individually in petri dishes and incubated at 37 °C for 24 h in a humid atmosphere. After incubation, each disk and the corresponding filter were together placed in 5 ml of TSB, sonicated for 30 sec in a sonicator water bath (Elma Transsonic T460, 35 kHz; Elma Schmidbauer GmbH, Singen, Germany) and vortexed for 1 min to dislodge adherent bacteria. This procedure does not affect bacterial viability 34 . Per sample, two independent ten-fold serial dilutions were made in a microtiter plate and duplicate 10 µl aliquots of the undiluted suspension and of the dilutions were pipetted onto blood agar plates. The blood agar plates were incubated overnight at 37 °C and the numbers of colonies were counted the following day.
MOUSE EXPERIMENTAL BIOMATERIAL-ASSOCIATED INFECTION MODEL
An established subcutaneous biomaterial-associated infection model to assess prevention of infection was used 30, [35] [36] [37] . In this model, planktonic bacteria are injected along the implant, as opposed to biofilm treatment models, where bacterial biofilm if pre-grown on the implant surface prior to implantation 30 . The mouse study was approved by the Animal Ethical Committee of the Academic Medical Center at the University of Amsterdam, the Netherlands. Specific pathogenfree C57BL/6J OlaHsd immune competent female mice (Envigo, Horst, The Netherlands), aged 7 to 9 weeks old and weighing 17 to 20 g, were used.
Mice were anesthetized with 2% isoflurane (Pharmachemie) in oxygen in a laminar flow cabinet, followed by a subcutaneous injection of buprenorphine (Temgesic, RB Pharmaceuticals Limited; 0.05 mg/kg) 15 min prior to the surgical procedure for pain control. The backs of the mice were shaved and disinfected with 70% ethanol. On each side, an incision of 0.5 cm was made 1 cm lateral to the spine. Subsequently, the (coated) titanium biomaterials were implanted subcutaneously with minimal tissue damage using a transponder, specifically designed for these implants 30 . The incisions were closed with a single 0/6 vicryl stitch (Vicryl, Ethicon).
S. aureus GFP was cultured in TSB with 10 µg/ml chloramphenicol to the mid-logarithmic growth phase. The bacteria were washed in 0.9% NaCl (saline) and resuspended in saline, based Labs, H-5000) was applied and the sections were covered with a coverslip.
Between 2 and 5 multispectral imaging data sets were acquired of the immunohistochemically stained sections using the Nuance Imaging System (PerkinElmer/ Caliper Life Science) at 420 to 720 nm with intervals of 20 nm. The data sets were spectrally unmixed to identify the different cell types (macrophages, neutrophils and bacteria). In the negative controls without primary antibodies no staining was observed.
STATISTICAL ANALYSIS
All statistical analyses were performed in Graphpad Prism. For CFU counts, two-sample comparisons were made using a two-tailed Mann-Whitney rank sum test. The significance of differences between the frequencies of categorical variables was determined using Fisher's exact test. For all tests, p-values of ≤0.05 were considered significant.
RESULTS
COATING SYNTHESIS AND CHARACTERIZATION
A procedure for the preparation of the coating formulation was established utilizing the diglycidyl ether of glycerol as the epoxy resin, IPD for curing and dopamine to optimize the adhesion to titanium (Figure 1a) . Ensuring a close to equimolar ratio of NH/epoxy in the coating formulations (Table 1) Table 1 ). No differences were observed between the mechanical properties of the separate batches of identical formulations.
The SEM analyses of the non-coated surfaces showed a rough topography with visible grooves (Figure 2a ) and enhanced local roughness (Figure 2c) , which was also affirmed by the 3D morphology as assessed by AFM with an estimated average surface roughness (R a ) of 861.9 ± 27 nm (Figure 2e) . In contrast, the CHX 10 -coated samples showed a smooth ( Figure   2f ; R a of 530.5 ± 15 nm), compact and non-porous layer completely covering the original titanium topography (Figure 2b and 2d) . In addition, white structures protruding from the 80 CHAPTER 4 surface are visible on the coated samples both in SEM (Figure 2b and 2d) and AFM ( Figure   2f ). The nature of these protrusions remains elusive.
IN VITRO CHLORHEXIDINE RELEASE
The release curves show that the total amount of released chlorhexidine can be adjusted by changing the concentration of chlorhexidine in the formulation, i.e. 5 versus 10 wt% chlorhexidine (CHX 5 and CHX 10 in Figure 3) . Chlorhexidine was released from the CHX 5 -and 
IN VITRO SURFACE BACTERICIDAL ACTIVITY
The CHX 5 and CHX 10 coatings applied on titanium disks completely killed the S. aureus inoculum after 24 h of incubation (Figure 4 ). After washing with PBS for 24 h, both the CHX 5 and CHX 10 coatings remained fully bactericidal. The coating without chlorhexidine (CHX 0 ) did not reduce survival of S. aureus, showing that the bactericidal activity of the CHX 5 and CHX 10 coatings was due to the release of chlorhexidine.
IN VIVO ANTIBACTERIAL ACTIVITY OF CHX 10 -COATED TITANIUM IMPLANTS IN MOUSE EXPERIMENTAL BAI
In a first experiment, mice were either sham-operated or they received non-coated, CHX 0 -, or CHX 10 In order to allow evaluation of an effect of the CHX 10 coating on implant colonization, we repeated the experiment with an S. aureus GFP inoculum of 10 6 CFU with expected higher levels of in vivo colonization of non-coated implants. We used the coating with the highest chlorhexidine content (CHX 10 ) and non-coated implants for comparison. With this increased inoculum size, both the implant surfaces and the peri-implant tissues were highly colonized in the group of mice with non-coated implants (Figure 6 ). At 1 day after challenge 100% of the tissues and 89% of the implants, and at 4 days 83% of the tissues and 28% of the implants were culture positive in this group, and numbers of CFU retrieved from the implants and the surrounding tissue were higher with this increased inoculum size than with an inoculum of 10 5 CFU used in the previous experiment (compare Figure 6 to Figure 5 ).
At 1 day after challenge, the CHX 10 coating significantly reduced the number Figure 4 . Surface bactericidal activity of chlorhexidine-releasing epoxy-based coating on titanium disks against 2 × 10 5 CFU S. aureus. The survival of the bacteria 24 h after application on unwashed (white bars) and washed (24 h in PBS; black bars) disks is shown. Non-coated, titanium disks without coating; CHX 0 , titanium disks with coating not containing chlorhexidine; CHX 5 and CHX 10 , titanium disks with coating containing 5 or 10 wt% chlorhexidine, respectively. The detection limit was log 2.7 CFU of S. aureus. 
HISTOLOGY
To assess the influence of the coatings on the local immune response, we simultaneously stained polymorphonuclear neutrophils (PMNs), macrophages and bacteria in single histological slides of tissue sections, and visualized the cells using multispectral imaging.
At 1 day after challenge, a strong infiltration of PMNs as well as of macrophages around the non-coated titanium samples was observed (Figure 7a) . Around the CHX 10 -coated implants, clearly less PMNs were present at this early time point. At 4 days after challenge the foreign body response had progressed from neutrophil to macrophage (F4/80 positive cells) predominance, around both the non-coated and the CHX 10 -coated titanium implants (Figure 7c and 7d) . So, in line with our macroscopic observations, there were no microscopic signs of in vivo adverse effects such as excessively increased or protracted neutrophildominated inflammatory responses nor necrosis which might have been caused by the coating components or the chlorhexidine released. 
DISCUSSION
We have developed an epoxy-based mechanically stable coating for titanium implants providing a predetermined release of chlorhexidine to prevent biomaterial-associated infection (BAI). The epoxy-based coatings containing 5 or 10 wt% chlorhexidine, CHX 5 and CHX 10 , displayed an initial burst release in the first 24 h and the residual release occurring within 4 days. Additional in vitro studies showed that the coating completely eradicated the S. aureus inoculum even after washing for 24 h in PBS. The CHX 10 coating prevented mouse subcutaneous biomaterial-associated S. aureus infection and did not show macroscopic nor microscopic signs of adverse effects.
Coatings and materials derived from epoxy resins have found widespread use in numerous applications. Because of their good adhesion properties and excellent mechanical stability, epoxy-based coatings are highly suited for metallic orthopaedic implants, which are often inserted under mechanical stress. These coatings are particularly suited for non-cemented implants which in contrast to cemented implants cannot be protected by e.g. antibiotic releasing bone cement 40, 41 or other antimicrobial approaches such as the use of bioactive glass 42, 43 , and are more prone to recurrent infection 44, 45 .
Perhaps the most well-known epoxy resin imparting good mechanical properties to its derived coatings is the diglycidyl ether of bisphenol-A (DGEBA) 20 . Cured networks of DGEBA and isophorone diamine (IPD) for biomedical applications indeed showed respectable mechanical properties and good biocompatibility in vitro 20 . However, bisphenol A derivatives are under continuous debate for their safety 46 . Therefore, we selected the diglycidyl ether glycerol as the epoxy resin, to be cured with IPD, a system shown to be hemocompatible 47 , and not toxic in a rabbit bone implant model 48 . Ensuring a nearly stoichiometric ratio of NH to epoxy groups resulted in a highly crosslinked network.
To further enhance adhesion of the coating to the titanium, dopamine was added to the formulation. The coating did not show any damage after extensive testing in the double rub as well as tape adhesion assays, illustrating its excellent mechanical properties.
The coating therefore is a promising candidate for application to titanium implants in orthopaedics and dentistry.
Although antibiotic releasing coatings are widely used for different medical applications, e.g. in sutures and central venous and urinary tract catheters, antibiotic release coatings for orthopaedic devices remain mainly experimental. A study in rabbits with titanium fixation plates coated with poly-L -lactide (PLLA) containing a combination of rifampicin and fusidic acid placed on the tibia showed a significant reduction in S.
aureus infection after 28 d 49 . Direct application of rifampicin and minocycline on titanium significantly reduced S. aureus colonization of femoral medullary nails and device-related osteomyelitis in rabbits after 1 week 50 . In a rabbit tibia S. aureus infection model, the application of tobramycin to hydroxyapatite-coated titanium implants reduced infection rates and improved osseointegration after 28 days 51 . In another rabbit study, the combination of hydroxyapatite with gentamicin also showed significant reduction in S.
aureus infection rates, good biocompatibility and bone integration as observed with pure hydroxyapatite 52 . A gentamicin-loaded biodegradable poly( D , L -lactide) (PDLLA) coating on titanium Kirschner wires showed a significant reduction in implant-related infection after 6 weeks of implantation in a rat tibia infection model 53 . A recent prospective study of the 54 . However, antibiotic-releasing coatings have two major disadvantages. Due to the worldwide rapid increase in antibiotic resistance there is a risk that a patient will have an infection with a bacterium which is resistant to the released antibiotic. Conversely, due to the local release, graded concentrations of antibiotic will be present near the implant, increasing the risk of selection of resistant bacteria and thus contributing to resistance development and ensuing implant infection.
In order to avoid antibiotics, we sought to use an antiseptic as the antimicrobial agent for our coating. One of the most frequently used antiseptics is chlorhexidine, with a broad spectrum of activity against Gram-positive and Gram-negative bacteria and yeasts, and with acceptable tolerability and a good safety record 55 . Chlorhexidine has been approved by the American Food and Drug Administration (FDA) for application to intracorporally used medical devices, such as surgical meshes 56, 57 and intravenous catheters 17 , and has a history of successful clinical 58 and experimental use in preventing biomaterial-associated and other infections 59, 60 . Chlorhexidine combined with chloroxylenol in a dip-coating on rabbit tibia intramedullary nails prevented experimental S. aureus osteomyelitis 18, 19 .
Chlorhexidine is an important agent in the prevention of the spread of antibiotic resistant organisms and hospital-acquired infections 61 . The effectiveness and widespread use of chlorhexidine has led to some concerns regarding the emergence of bacterial resistance 62, 63 , including MRSA resistance 61 . However, reported levels of susceptibility of the bacterial isolates are still several orders of magnitude below the clinically applied dosages 63 .
We tailored our coatings to release most of the chlorhexidine within the first 24 h. As proof of concept for prevention of infection, we studied efficacy in our mouse subcutaneous implant infection model. The CHX 10 coating proved to be highly efficacious in preventing S. aureus infection and did not cause any signs of adverse effects. Interestingly, at 1 day post challenge only few bacteria were observed in histology, and there was only a relatively low level of neutrophil influx in the tissue surrounding the CHX 10 -coated implants. This low influx likely is due to the efficacy of the coating to kill the S. aureus bacteria rapidly, thereby reducing e.g. local complement activation and consequent neutrophil attraction.
Studies in a rabbit tibia intramedullary nail infection model with titanium implants with the same epoxy-based chlorhexidine-releasing coatings as used in our study, showed no signs of local nor of systemic toxicity during the 6 week experiment 48 . Moreover, significantly higher bone apposition on the implant surface of both the CHX 0 (98.8% coverage) and CHX 10 (81.3% coverage) than on non-coated titanium nails (71.5% coverage) was observed after 6 weeks. However, in contrast to our mouse results, no protection against S. aureus infection was observed. This may have been due to the prolonged time period of the rabbit experiments. In the first post-operative week the rabbits showed lower 18 F-FDG tracer uptake suggesting lower levels of inflammation. This might indicate that a partial suppression of the S. aureus infection might have occurred in the first days of the experiment. Apparently, the chlorhexidine reservoir and its release profiles would need to be optimized for the rabbit model, which certainly is possible with this coating technology.
Bacteria colonizing the surface of a biomaterial not only are a focus of a localized biofilm infection, but can also be the source of tissue colonization 30 . Conversely, bacteria residing in the tissue can be a cause of infection after re-implantation, in experimental infection 11 as well as in patients. Tissue-residing bacteria can be hard to eradicate by antibiotic treatment 10, 64 , and in patients may necessitate a prolonged regimen of systemic and local antibiotic treatment prior to re-implantation 65 . Thus, prevention of bacterial colonization of tissue surrounding implants is of vital importance. In our study, large numbers of bacteria were cultured from the tissues around the non-coated implants.
Particularly at 4 days after challenge, these bacteria were co-localized with macrophages, suggesting that the macrophages were not effectively killing the bacteria. This phenomenon has been observed in many earlier studies 34, 66, 67 . From the tissue around the CHX 10 -coated implants however, only few bacteria were cultured, and in histology few bacteria were seen. Apparently, the rapid initial release of chlorhexidine killed the vast majority of the infecting bacteria, preventing formation of a biofilm on the implant surface as well as colonization of the tissue, thus protecting both these sites against infection.
CONCLUSION
Taken together, our mechanically stable chlorhexidine-releasing epoxy-based coating on titanium holds promise for further development towards clinical application. Because of its mechanical stability it is suited for all types of bone implants, including but not limited to non-cemented orthopaedic implants, and possibly dental implants as well. Our coating
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provides a good alternative for coatings releasing conventional antibiotics and therefore has the potential not only to prevent implant infection but also contribute to reduction of antibiotic resistance development.
